We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

140 hedge funds and large institutions have $756M invested in Alder Biopharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 32

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

6% more funds holding

Funds holding: 132140 (+8)

6% less capital invested

Capital invested by funds: $803M → $756M (-$47.3M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

31% less call options, than puts

Call options by funds: $799K | Put options by funds: $1.17M

Holders
140
Holders Change
+8
Holders Change %
+6.06%
% of All Funds
3.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
27
Increased
58
Reduced
32
Closed
19
Calls
$799K
Puts
$1.17M
Net Calls
-$367K
Net Calls Change
+$165K
Name Holding Trade Value Shares
Change
Change in
Stake
FIM
151
Foresters Investment Management
New York
-$25K -2,064 Closed
MA
152
MUFG Americas
New York
-$13K -1,060 Closed
CHP
153
Cable Hill Partners
Oregon
-$1.94K -174 -93%
MAM
154
Meeder Asset Management
Ohio
-$1K -73 Closed
PNC Financial Services Group
155
PNC Financial Services Group
Pennsylvania
+$201 +18 New
MOS
156
MGO One Seven
Ohio
+$246 +22 New
GWS
157
Glassman Wealth Services
Virginia
+$290 +26 New